
Conference Information
Dear distinguished colleagues, researchers, and healthcare leaders,
Welcome to the Indonesia Clinical Genomics and Precision Medicine Forum 2026, jointly organized by BGI Group, MGI Tech, and NGI. This forum brings together experts from Indonesia and China to exchange knowledge and strengthen collaboration in clinical genomics and precision medicine at:
Date: 26 September 2026
Time: 08.30 - 17.00
Venue: The Westin Jakarta, Indonesia
As Indonesia continues to advance its digital health transformation, omics technologies are playing an increasingly important role in how diseases are understood and managed in more personalized ways. This forum reflects our shared commitment to advancing precision medicine by fostering scientific collaboration, encouraging technological innovation, and strengthening strategic partnerships across the region.
Through scientific presentations, technology showcases, and interdisciplinary discussions, participants will explore the latest developments in clinical genomics and discover how integrated genomic solutions can support the future of healthcare.
We look forward to welcoming you to Jakarta and to collaborating in advancing precision medicine for the benefit of our international community.
Meeting's Mission
Speakers
Mr. Jeremy, Cao
Vice President of BGI Group

Indri Rooslamiati, M.Sc.,Apt
Director of Center for Biomedical and Health Genomics and INA-CRC
Prof. Dr. Dr. M. Alamsyah Aziz, Sp.OG, Subsp.KFM, M.Kes, FISOG
Chairman of the Indonesian Fetal Maternal Medicine Association (HKFM)
Dr. dr. Raden Aditya Kusuma is a Fetomaternal Medicine Consultant at RS Anak dan Bunda (RSAB) Harapan Kita, with a strong focus on the care of high-risk pregnancies and fetal health. His expertise includes advanced prenatal screening and diagnosis, fetal growth and well-being assessment, and the management of complex maternal conditions and multiple pregnancies. He also provides genetic counseling to support informed decision-making throughout pregnancy. Through the use of advanced diagnostic technologies, he is dedicated to promoting early detection and comprehensive care for both mother and fetus.

Dr. dr. R. Dina Garniasih, Sp. A., Subsp. H. O. (K)
Pediatric Hemato-Oncologist - RSAB Harapan Kita
Dr. Dina Garniasih is a Pediatric Hematology-Oncology Consultant at RSAB Harapan Kita with extensive expertise in childhood cancers, thalassemia, hemophilia, and other hematologic disorders. Combining clinical practice, research, and academic leadership, she is dedicated to delivering evidence-based, patient-centered care for children with complex medical conditions. Her work focuses on improving early diagnosis, comprehensive treatment, and long-term outcomes through advances in pediatric hematology and precision medicine.

dr. Ludi Dhyani Rahmartani, Sp. A., Subsp. H. O. (K)
Pediatric Hemato-Oncologist - RSUPN Dr, Ciptomangunkusumo
Dr. Ludi Dhyani Rahmartani is a Pediatric Hematology-Oncology Consultant with expertise in pediatric cancers and thalassemia. Having completed advanced clinical training in Thailand, Singapore, the United Kingdom, and the United States, she brings extensive international experience to patient care and research. She is actively involved in advancing pediatric hematology-oncology and genomic medicine to improve outcomes for children with complex diseases
Dr. dr. Achmad Rafli, Sp.A, Subsp. Neuro(K), FICNA
Pediatric Neurologist - RSUPN Dr. Ciptomangunkusumo
